Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Multiple Myeloma”

359 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 359 results

Testing effectiveness (Phase 2)Looking for participantsNCT07045909
What this trial is testing

Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)

Who this might be right for
De Novo Multiple MyelomaAnitocabtagene Autoleucel
PETHEMA Foundation 30
Testing effectiveness (Phase 2)Looking for participantsNCT07106736
What this trial is testing

MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Study completedNCT02405364
What this trial is testing

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Not applicableLooking for participantsNCT07226609
What this trial is testing

A Dietary Study for People With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 220
Large-scale testing (Phase 3)Study completedNCT00551928
What this trial is testing

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaNewly Diagnosed Patients
Fondazione EMN Italy Onlus 402
Testing effectiveness (Phase 2)Study completedNCT02159365
What this trial is testing

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 84
Not applicableActive Not RecruitingNCT07026799
What this trial is testing

Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy

Who this might be right for
Multiple Myeloma Bone Lesions
University Hospital Heidelberg 50
Not applicableStudy completedNCT01508416
What this trial is testing

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Saint Etienne 71
Not applicableActive Not RecruitingNCT05889221
What this trial is testing

Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma MultipleMyeloma
Poitiers University Hospital 74
Not applicableLooking for participantsNCT06698887
What this trial is testing

Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)Study completedNCT00925821
What this trial is testing

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wuerzburg University Hospital 146
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Study completedNCT02937571
What this trial is testing

High Dose Carfilzomib for Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)WithdrawnNCT03608501
What this trial is testing

Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)UnknownNCT00378755
What this trial is testing

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 62
Not applicableStudy completedNCT00898066
What this trial is testing

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous/Nonmalignant Condition
SWOG Cancer Research Network 37
Testing effectiveness (Phase 2)Looking for participantsNCT06758375
What this trial is testing

Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Hospital Universitario Dr. Jose E. Gonzalez 10
Not applicableStudy completedNCT07206810
What this trial is testing

The Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Myeloma
The First Affiliated Hospital of Soochow University 419
Testing effectiveness (Phase 2)Ended earlyNCT01969565
What this trial is testing

Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 1
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Load More Results